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Abstract
Objectives The purpose of this study was to evaluate and com-
pare the osteoblastic differentiation ability of dedifferentiated fat
(DFAT) cells and adipose stem cells (ASCs) from the buccal fat
pad (BFP).
Materials and methods We isolated human DFAT cells and
ASCs from the BFP of a patient who underwent oral and
maxillofacial surgery and then analyzed their cell surface anti-
gens by flow cytometry. Then, the cells were cultured in oste-
ogenic medium for 14 days. Measurement of bone-specific
alkaline phosphatase (BAP), osteocalcin (OCN), and calcium
deposition and alizarin red staining were performed to evaluate
the osteoblastic differentiation ability of both cell types.
Results ASCs and DFAT cells were positive for CD90 and
CD105 and negative for CD11b, CD34, and CD45. BAP
(days 3 and 7), OCN (day 14), and calcium deposition
(days 7 and 14) within DFAT cell cultures were significantly
higher than those in ASC cultures. The alizarin red-stained area
in DFAT cell cultures, which indicates mineralized matrix de-
position, was stained more strongly than that in ASC cultures.
Conclusions The cell surface antigens of ASCs and DFAT
cells tend to be similar. Furthermore, the osteoblastic differ-
entiation ability of human DFAT cells is higher than that of
ASCs from the BFP.
Clinical relevance Isolation of DFATcells from the BFP has an
esthetic advantage because the BFP can be obtained via the oral
cavity without injury to the external body surface. Therefore, we
consider that DFAT cells from the BFP are an ideal cell source
for bone tissue engineering.
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Introduction
Adipose stem cells (ASCs) are isolated from adipose tissue
and can differentiate along multiple lineages including adipo-
cytes, osteoblasts, chondrocytes, myocytes, neuronal cells,
endothelial cells, and hepatocytes [1–3]. In addition, ASCs
are readily available in large quantities with minimal morbid-
ity and discomfort associated with harvest [1–4].
ASCs are extensively used for bone tissue engineering, and
their utility has been reported in various studies [5–7].
Recently, Farre-Guasch et al. [4] showed that ASCs from the
buccal fat pad (BFP) can differentiate into chondrocytes, oste-
oblasts, and adipocytes in vitro. Shiraishi et al. [8] reported that
ASCs from the BFP can form an engineered bone in the back
subcutaneous pockets of nude mice. Therefore, the BFP might
be a potential cell source for bone tissue engineering in oral and
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maxillofacial areas, because it is easy to harvest and provides a
reliable volume of tissue for oral surgeons.
However, ASCs are a heterogeneous cell population, par-
ticularly at early passages, because they are obtained from the
non-adipocyte fraction in adipose tissue, known as the stromal
vascular fraction (SVF) [1, 3, 9]. ASCs at passage 0 include
contaminating endothelial and smooth muscle cells and
pericytes [1]. Therefore, other stem cell sources with a high
purity are needed for improved safety in clinical application.
In contrast to ASCs, mature adipocytes are themost abundant
cell type in adipose tissue [10]. It has been shown that mature
adipocytes isolated from fat tissue can be dedifferentiated into
fibroblast-like cells by an in vitro dedifferentiation strategy
known as ceiling culture [10]. Yagi et al. [11] has established
an adipogenic progenitor cell line derived from the mature
adipocytes of ddY mice and named these cells dedifferentiated
fat (DFAT) cells. In addition, compared with ASCs, a relatively
homogeneous cell population of DFAT cells has been revealed
by flow cytometric analysis [10].
We have investigated bone tissue engineering using a com-
bination of DFAT cells and the self-assembling peptide
RADA16 or titanium fiber mesh as a scaffold and found that
DFAT cells proliferate and differentiate into osteoblasts
[12–14]. These findings prompted us to hypothesize that
DFAT cells are multipotent cells similar to ASCs and mesen-
chymal stem cells. However, there are no studies comparing the
osteoblastic differentiation ability of DFAT cells with ASCs.
The hypothesis more supported by the work carried out
would be that DFAT cells maintain a higher degree of
multipotency than ASCs, and therefore, they should have a
higher osteogenic potential. Thus, the purpose of this study
was to evaluate and compare the osteoblastic differentiation
abilities of DFAT cells and ASCs from the BFP in vitro.
Materials and methods
Isolation and culture of DFAT cells and ASCs
A humanBFPwas obtained from a female patient (34 years old),
who underwent oral and maxillofacial surgery at Osaka Dental
University Hospital, following written informed consent. The
patient was healthy and had no systemic disease. All procedures
were approved by the ethics committee of Osaka Dental
University (approval number 110714). We isolated DFAT cells
using the “ceiling culture method” as described in our previous
report [12]. Briefly, approximately 1 g of BFP was minced into
small pieces and then dissociated in a 0.1 % (w/v) collagenase
solution (collagenase type Ι; Wako Pure Chemical, Osaka,
Japan) at 37 °C for 1 h with gentle agitation. The cell suspension
was filtered through 150- and 250-μm nylon meshes to allow
cells to pass through and exclude unwanted stromal cells and
tissue. Floating mature adipocytes in the top layer were collected
and centrifuged at 135g for 3 min. Isolated mature adipocytes
were seeded in a 25-cm2 culture flask (Sumilon; Sumitomo
Bakelite, Tokyo, Japan) that was completely filled with
Dulbecco’s modified Eagle’s medium (DMEM; Nacalai
Tesque, Kyoto, Japan) supplementedwith 20% (v/v) fetal bovine
serum (FBS; lot number 1412447; Invitrogen, Life
Technologies, Carlsbad, CA) and antibiotics and antimycotics
(an antibiotic/antimycotic mixed stock solution consisting of
10,000 U/mL penicillin, 10,000 μg/mL streptomycin, and
25 μg/mL amphotericin B; Nacalai Tesque). The cells were then
incubated at 37 °C with 5 %CO2. The flask was positioned with
the adhesive culture surface facing upward, so that floating
adipocytes containing lipid droplets attached to the inner ceiling
surface of the flask. This method is referred to as “ceiling
culture” (Fig. 1). After 7 days, the medium was removed and
the flask was inverted. Fresh medium was added to barely cover
the bottom of the flask. The medium was then changed twice a
week. At confluency, the cells were passaged and used for
experiments.
We isolated ASCs according to a report by Zuk et al. [1]
(Fig. 1). The medium used for DFAT cell culture was also
applied to ASC culture. The culture medium for both cell
types was replaced twice a week. At confluency, the cells
were passaged and used for experiments.
Flow cytometric analysis
Cell surface antigens of passage 2 cells were analyzed by flow
cytometry. At 90 % confluence, DFAT cells and ASCs from
the BFP were detached by Accutase (Merck Millipore,
Billerica, MA) and then resuspended in phosphate-buffered
saline (PBS) at a density of 1×107 cells/mL. One hundred
microliters of each cell suspension was incubated with fluo-
rescently labeled antibodies against CD11b, CD34, CD45,
CD90, and CD105 (all purchased from BioLegend, San
Diego, CA) in the dark for 30 min on ice. Unbound antibodies
were washed out, and each cell sample was analyzed using a
Guava easyCyte Flow Cytometer (Merck Millipore). Positive
cells were counted and compared with the signals of the
corresponding antibody isotype controls.
DNA analysis
DFAT cells and ASCs were seeded in 12-well plates at a density
of 3×104 cells/well and incubated in standard medium at 37 °C
with 5 % CO2. At confluency, both cell types were cultured in
normalmedium (NM;DMEMsupplemented with 10%FBS) or
osteogenic medium [OM; NM supplemented with 10 % FBS,
100 nMdexamethasone (Sigma-Aldrich, St. Louis,MO), 50μM
L-ascorbic acid 2-phosphate (Sigma-Aldrich), and 10 mM
β-glycerophosphate (Sigma-Aldrich)] for 14 days. Bothmedium
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types were replaced twice a week. DNA content was measured
on days 3, 7, and 14. The medium was removed from each well,
and the cell layer was washed twice with PBS. Then, 300 μL of
0.2 % Triton X-100 was added to each well, and the cells were
removed using a cell scraper (BD, Franklin Lakes, NJ) to extract
the DNA. DNA content was measured with a Quant-iT™
PicoGreen® dsDNA Reagent and Kit (Invitrogen). Fifty micro-
liters of the sample was mixed with a DNA-binding fluorescent
dye solution (0.5μLPicoGreen reagent in 100μL1×TE buffer),
and the fluorescence intensity was measured with a microplate
reader (excitation 450 nm/emission 510 nm, SpectraMax® M5;
Molecular Devices, Sunnyvale, CA) (n=4).
Bone-specific alkaline phosphatase measurement
Bone-specific alkaline phosphatase (BAP) activity was mea-
sured with Osteolinks BAP (DS Pharma Biomedical, Osaka,
Japan). The same samples (20 μL) used for DNA measure-
ment were added to each well of a BAP antibody-coated
microtiter plate and then incubated at room temperature for
3 h. After four washes with the wash buffer supplied with the
kit, 150 μL of substrate solution (disodium p-nitrophenyl
phosphate) was added to each well, followed by incubation
at room temperature for 30 min. After 100 μL of stop solution
was added to each well, the absorbance was measured at
405 nm with the SpectraMax® M5 (n=4).
Osteocalcin measurement
DFAT cells and ASCs were cultured under the same condition
described in “DNA analysis,” and then the expression of
osteocalcin (OCN) in both cell types was determined with a
Gla-type Osteocalcin EIA Kit (Takara Bio, Shiga, Japan). On
days 3, 7, and 14 of culture, the mediumwas removed, the cells
were washed with PBS, and 300 μL of 10 % formic acid was
added to eachwell, followed by removal of the cells using a cell
scraper. Samples (100 μL) were added to each well of an anti-
OCN antibody-coated microtiter plate and then incubated at
room temperature for 2 h. After three washes with PBS, 100μL
of a peroxidase-conjugated anti-OCN antibody solution was
added to each well, followed by incubation at room tempera-
ture for 1 h. After four washes with PBS, 100 μL of substrate
solution (tetramethylbenzidine) was added to each well,
followed by incubation at room temperature for 15 min. After
100 μL of stop solution was added to each well, the absorbance
was measured at 450 nm with the SpectraMax® M5 (n=4).
Fig. 1 Isolation of human dedifferentiated fat (DFAT) cells and adipose
stem cells (ASCs) from the buccal fat pad (a). Morphology of ASCs (b)
and DFAT cells (c) from the BFP at 7 days after dissemination of
the stromal vascular fraction and the beginning of ceiling culture,
respectively. Red arrows indicate lipid droplets in mature adipo-
cytes (c). Scale bars = 100 μm
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common antigen), and CD90 and
CD105 (mesenchymal
stem/progenitor cell markers) on
adipose stem cells (ASCs) and
dedifferentiated fat (DFAT) cells
from the buccal fat pad at passage
2. Green open histograms
represent antibody isotype
controls, and purple closed
histograms represent a sample
stained with specific antibodies
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Calcium measurement
Calcium deposition was measured with a Calcium E-test Wako
(Wako Pure Chemical). Two milliliters of monoethanolamine
buffer was added to 50 μL of the same sample used for OCN
measurement, followed by thorough mixing. After 1 mLmeth-
yl xylenol blue coloring agent was added to the mixture, the
absorbance was measured at 610 nm with the SpectraMax®
M5 (n=4).
Alizarin red staining
DFATcells and ASCs were cultured under the same condition
described in DNA analysis, and then, both cell types were
stained using alizarin red to assess mineralization. On days 3,
7, and 14 of culture, the medium was removed, and the cells
were fixed in 95 % ethanol for 10 min. Then, the cells were
rinsed with distilled water and stained with 1 % alizarin red S
(pH 6.1) for 30 min. The stained cells were washed with
distilled water three times with gentle agitation.
Statistical analysis
Data are expressed as the mean ± standard deviation.
Statistical analysis was performed between DFAT cells and
ASCs cultured in the same medium (e.g., ASC NM vs. DFAT
cell NM) to compare the proliferation and osteoblastic differ-
entiation ability of both cell types. Intergroup comparisons
were performed using the unpaired t test. Differences were
considered significant at p<0.05.
Results
Flow cytometric analysis
Human DFAT cells from the BFP at passage 2 were positive
for CD90 and CD105 (mesenchymal stem/progenitor cell
markers) and negative for CD11b (monocyte marker), CD34
(hematopoietic progenitor cell marker), and CD45 (leukocyte
common antigen). Similar to DFATcells, ASCs from the BFP
Fig. 3 Proliferation and osteoblastic differentiation of dedifferentiated fat
(DFAT) cells and adipose stem cells (ASCs). DNA (a), BAP (b), OCN (c),
and calcium (d) deposition of DFAT cells and ASCs cultured in normal
medium (NM) and osteogenic medium (OM). Data are the mean ± standard
deviation. *p<0.05; **p<0.01
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at passage 2 were positive for CD90 and CD105 and negative
for CD11b, CD34, and CD45 (Fig. 2).
Proliferation and osteoblastic differentiation of DFAT cells
and ASCs
As an indicator of cell proliferation, the DNA content of ASCs
cultured in OM was significantly higher than that of DFAT
cells on day 3 (p<0.05). However, no significant difference
was found at all other time points. BAP is synthesized by
osteoblasts and can be used as an index for the rate of bone
formation [15]. The BAP expression of DFATcells cultured in
NM was significantly higher than that of ASCs on days 3, 7,
and 14 (p<0.01). Furthermore, BAP expression of DFATcells
cultured in OM was significantly higher than that of ASCs on
days 3 and 7 (p<0.05). The expression of OCN, a marker of
late-stage osteoblastic differentiation [16], in DFAT cells cul-
tured in NM and OM was significantly higher than that in
ASCs on day 14 (p<0.01). The calcium deposition, a marker
of terminal-stage osteoblastic differentiation [17], of DFAT
cells cultured in NM was significantly higher than that of
ASCs on day 14 (p<0.01). Moreover, the calcium deposition
of DFAT cells cultured in OM was significantly higher than
that of ASCs on days 7 and 14 (p<0.01) (Fig. 3).
Morphology and alizarin red staining of DFATcells and ASCs
cultured in NM and OM
Under a phase contrast microscope, some mineralized nodule
formations were observed in DFAT cells cultured in OM on
day 7, which increased on day 14. ASCs cultured in OM
showed some mineralized nodule formations on day 14 only,
Fig. 4 Morphology of dedifferentiated fat (DFAT) cells and adipose stem
cells (ASCs) cultured in normal medium (NM) and osteogenic medium
(OM). A yellowish brown mineralized extracellular matrix was slightly
observed in DFAT cells cultured in OM for 7 days and in ASCs cultured
in OM for 14 days. A significant mineralized extracellular matrix was
observed in DFAT cells cultured in OM for 14 days. Scale bars = 100 μm
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but they were fewer than those observed in DFAT cells. There
were no mineralized nodule formations in both cell types
cultured in NM at all time points (Fig. 4).
Red areas stained by alizarin red are an indication of
calcium deposition. The plates containing DFATcells cultured
in OM for 7 days and ASCs cultured in OM for 14 days were
stained weakly by alizarin red. However, the plate containing
DFAT cells cultured in OM for 14 days was stained strongly
using alizarin red (Fig. 5).
Discussion
In the present study, we compared the proliferation and oste-
oblastic differentiation of DFAT cells and ASCs. There were
no significant differences in the DNA analysis of DFAT cells
and ASCs, except for those cultured in OM on day 3.
Therefore, the proliferation rates of DFAT cells and ASCs
are considered to be similar. However, the expression of
osteoblastic differentiation markers (BAP, OCN, and calcium)
in DFAT cells was more prevalent than that in ASCs. These
results and those of alizarin red staining indicate that the
osteoblastic differentiation ability of human DFAT cells is
higher than that of ASCs. Therefore, DFAT cells have an
advantage over ASCs in bone tissue engineering because the
induction of osteoblasts from DFAT cells is more effective.
The OM applied in this study has been widely used to
induce osteoblastic differentiation of ASCs [1, 4, 18, 19] and
DFAT cells [10, 12]. Therefore, we consider that the OM did
not contribute to the significant differences in the expression
of osteoblastic differentiation markers between ASCs and
DFAT cells.
DFAT cells are isolated from mature adipocytes in adipose
tissue as shown in Fig. 1. After the adipose tissue was minced
and digested in a collagenase solution, the mature adipocytes
containing lipid droplets were suspended and could be sepa-
rated from the SVF by centrifugation. Almost all floating cells
(over 98 %) have been reported to be mature adipocytes that
comprise a highly homogeneous fraction [20]. Accordingly,
DFAT cells have been reported as a homogeneous cell popu-
lation because these cells are isolated by collecting the floating
pure cell population, followed by ceiling culture using the
buoyancy of the adipocytes [10, 12, 20, 21]. Conversely,
ASCs are a heterogeneous cell population because they are
isolated from the SVF that contains many cell types, but ex-
cluding mature adipocytes. Compared with ASCs, Matsumoto
et al. have reported that DFAT cells are a much more homoge-
neous cell population, because human ASCs at passage 1 are
Fig. 5 Alizarin red staining of dedifferentiated fat (DFAT) cells and
adipose stem cells (ASCs) cultured in normal medium (NM) and osteo-
genic medium (OM). Red areas stained by alizarin red indicate calcium
deposition. The wells containing DFAT cells cultured in OM for 7 days
and ASCs cultured in OM for 14 days were stained weakly by alizarin
red, whereas those containing DFAT cells cultured in OM for 14 days
were stained strongly by alizarin red. Scale bars = 100 μm
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13.3 % positive for CD11b (monocyte marker) and 12.8 %
positive for CD45 (leukocyte common antigen), whereas hu-
manDFATcells at passage 1 are negative for thesemarkers [10].
Therefore, populations of DFAT cells may include significantly
more undifferentiated multipotent cells than those of ASCs.
Consequently, DFAT cells might maintain a higher degree of
multipotency than that of ASCs, and the osteoblastic differenti-
ation ability of DFAT cells may be higher than that of ASCs.
However, the ASCs and DFAT cells used in this study were
negative for CD11b and CD45, and we did not show that the
DFAT cells were a more homogeneous cell population than the
ASCs population. Matsumoto et al. used ASCs and DFAT cells
at passage 1 [10], whereas both cell typeswere used at passage 2
in this study. It is possible that the difference between our flow
cytometry data and previous report data [10] was because of the
difference in passage number. The difference of the osteoblastic
differentiation ability of DFAT cells and ASCs was not because
of the difference of purity in the cell populations. Therefore, it is
unknown why the osteoblastic differentiation ability of DFAT
cells is higher than that of ASCs. More recently, we have
reported the difference of the osteoblastic differentiation ability
of human DFAT cells and human bone marrow mesenchymal
stem cells (BMSCs) [22]. Gene expression of Runx2
(a master regulator of osteoblast development), alkaline phos-
phatase activity, OCN expression, and calcium deposition is
higher in DFAT cells than that in BMSCs, although the reasons
are unclear. Based on the present study, we believe that the
osteoblastic differentiation ability of DFAT cells is higher than
that of not only BMSCs but also ASCs.
Our study is the first report of DFAT cells isolated from the
BFP that is easily accessible, exhibits rich vascularization, and
is widely used in oral surgery to repair bone and periodontal
defects [23–25]. Harvesting of the BFP is a simple procedure
that requires a minimal incision with local anesthesia and
causes minimal donor site morbidity [4]. Furthermore, com-
pared with subcutaneous adipose tissue, there might be an
esthetic advantage using the BFP because adipose tissue can
be obtained from the BFP via the oral cavity without injury to
the external body surface.
In summary, the advantages of DFAT cells from the BFP
are as follows: (1) their osteoblastic differentiation ability is
higher than that of ASCs, and (2) they are easily harvested by
an oral surgeon without an esthetic impact. We consider that
DFAT cells from the BFP, which possess the beneficial char-
acteristics mentioned above, are an ideal cell source for bone
tissue engineering.
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